Oxygen Biotherapeutics, Inc. To Present at OneMedForum 2010

DURHAM, N.C., Jan. 11  /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT)  announced today that company chairman and CEO Chris Stern will present at the OneMedForum 2010 investor conference in San Francisco on Wednesday, Jan. 13, 2010.

The presentation, limited by conference organizers to 10 minutes per company, will be at 9:00 a.m. pacific time and will be webcast live. A link to the webcast will be available the day of the presentation at the following url: http://www.onemedplace.com/onemedforum/index.php?option=com_content&task=view& id=96.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications which are being marketed under the Dermacyte name. More information is available at http://www.oxybiomed.com/. 

DATASOURCE: Oxygen Biotherapeutics, Inc.



CONTACT:  Abe Wischnia of Abe Wischnia & Associates, [phone], for

Oxygen Biotherapeutics, Inc.



Web Site:  http://www.oxybiomed.com/ 

Copyright